Jin Biotech rises 5.15% amid rising trend in anthelmintic drugs (including Fenbendazole) theme

On the 10th, the deworming drug theme (including Fenbendazole) showed strength by rising 3.91% compared to the previous day, with Jin Biotech, a related stock drawing attention, soaring 5.15% from the previous day. Jin Biotech is known as a manufacturer of functional feed additives and veterinary pharmaceuticals.

[Graph] Major stock price changes in the deworming drug theme (including Fenbendazole)



According to provisional data compiled at 11:59, foreign investors have been making large net purchases of Jin Biotech, buying 40,500 shares.

[Table] Net purchases by foreigners and institutions (unit: 10,000 shares)



According to the analysis by Thinkpool Robo Algorithm RASSI, Jin Biotech’s quant financial score is 27.42 points, ranking 3rd within the theme. Jin Biotech especially showed relatively high financial stability scores. This indicates that Jin Biotech’s ability to respond to internal and external economic environment changes is better compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of the robo algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.